Chiara Molinelli, Oncologist and Medical Research Fellow at Ospedale San Martino Genova, shared a post on X:
“For those ESMOBreast24 check out at the poster session our Gruppo Italiano Mammella (GIM) analysis about the predictive role of Human Epidermal Growth Factor Receptor 2 (HER2) low status in patients with metastatic breast cancer treated with Cyclin-Dependent Kinase (CDK) 4/6 inhibitors in I line and some interesting data about II line treatment will be available too!”
Source: Chiara Molinelli/X